p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer.

Saved in:
Bibliographic Details
Title: p300 is upregulated by docetaxel and is a target in chemoresistant prostate cancer.
Authors: Gruber M; Division of Experimental Urology, Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Ferrone L; Division of Experimental Urology, Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.; Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy., Puhr M; Division of Experimental Urology, Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Santer FR; Division of Experimental Urology, Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Furlan T; Division of Experimental Urology, Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Eder IE; Division of Experimental Urology, Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Sampson N; Division of Experimental Urology, Department of Urology, Medical University of Innsbruck, Innsbruck, Austria., Schäfer G; Department of Pathology, Neuropathology, and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Austria., Handle F; Division of Experimental Urology, Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.; Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium., Culig Z; Division of Experimental Urology, Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.
Source: Endocrine-related cancer [Endocr Relat Cancer] 2020 Mar; Vol. 27 (3), pp. 187-198.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioScientifica Country of Publication: England NLM ID: 9436481 Publication Model: Print Cited Medium: Internet ISSN: 1479-6821 (Electronic) Linking ISSN: 13510088 NLM ISO Abbreviation: Endocr Relat Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1479-6821
DOI:10.1530/ERC-19-0488